Metolazone Therapy for Heart Failure with Impaired Renal Function

Rationale for Adding Metolazone

In severe chronic heart failure with persistent fluid retention despite high-dose loop diuretics, the European Society of Cardiology recommends adding metolazone with frequent monitoring of creatinine and electrolytes 1
As renal function declines, the effectiveness of loop diuretics like furosemide diminishes due to reduced drug delivery to their site of action and fewer functioning nephrons 2

The American College of Cardiology notes that patients like this one, who have already demonstrated inadequate response to high-dose furosemide alone, may benefit from the addition of metolazone to their treatment regimen 3

The European Society of Cardiology and other guidelines recommend checking serum electrolytes (particularly potassium, sodium, and magnesium) within 5-7 days of initiating combination therapy 1, 4
Monitoring renal function closely is crucial, as combination diuretic therapy increases the risk of worsening renal function, according to the American College of Emergency Physicians 5
Regular weight monitoring is necessary to assess fluid status and guide diuretic dosing, as suggested by clinical guidelines 6

Combination diuretic therapy significantly increases the risk of electrolyte abnormalities, particularly hypokalemia and hypomagnesemia, and guidelines recommend consideration of adding a potassium-sparing diuretic or ACE inhibitor to help prevent electrolyte depletion 6, 4
Monitoring for signs of diuretic-induced myopathy, which can occur with electrolyte depletion and is more common with combination diuretic therapy, is advised by clinical guidelines 4